Vanadium is an ultratrace element present in the human body in microgram quantities, naturally occurring in a variety of foods including shellfish, mushrooms, and black pepper. It exists in multiple oxidation states, with vanadyl (IV) and vanadate (V) being the most biologically relevant forms studied in supplementation. Research interest has centered almost entirely on its ability to mimic insulin action at the cellular level.

Vanadium compounds, particularly vanadyl sulfate and BMOV, appear to exert insulin-mimetic effects by inhibiting protein tyrosine phosphatases (PTPs) — specifically PTP1B — which normally terminate insulin receptor signaling. By inhibiting PTP1B, vanadium prolongs activation of the insulin receptor and downstream signaling cascades including the PI3K/Akt pathway, enhancing glucose uptake in skeletal muscle and suppressing hepatic glucose production. It may also modestly enhance glycogen synthesis in muscle and liver tissue.

Vanadyl sulfate capsules and tablets are the most commercially available forms, typically standardized at 10–50 mg elemental vanadium equivalents per serving. BMOV has been used in clinical research protocols but is not widely available commercially. Powder forms of vanadyl sulfate are also sold and are occasionally mixed into pre-workout or glucose-disposal formulas.

• Type 2 Diabetes
• Insulin Resistance
• Blood Sugar Regulation

• Shellfish (oysters, clams, mussels)
• Mushrooms
• Black pepper
• Dill and parsley
• Whole grains (oats, whole wheat)

• Gastrointestinal distress (nausea, diarrhea, cramping) — most common, dose-dependent
• Green discoloration of the tongue — a benign cosmetic effect reported with vanadyl sulfate
• Fatigue and malaise at higher doses
• Potential nephrotoxicity with prolonged high-dose use (primarily from animal data; limited human evidence)
• Potential hepatotoxicity at excessive doses (primarily from animal and in vitro data)
• Hypoglycemia risk when combined with antidiabetic medications

• Recommended daily: 10–50 mg/day elemental vanadium as vanadyl sulfate for blood sugar support; clinical trials have used up to 100 mg/day but higher doses increase GI and toxicity risk. No established Recommended Daily Allowance (RDA) exists for vanadium; the Tolerable Upper Intake Level (UL) has been set at 1.8 mg/day by the Institute of Medicine for dietary intake, though clinical research has used far higher supplemental doses under supervised conditions.
• Best time of day: Divided doses with meals (e.g., with breakfast and dinner) to reduce gastrointestinal side effects
• With or without food: Take with food — food co-ingestion improves tolerability and may modestly support absorption of vanadyl sulfate
• Time to effect: 4–6 weeks for observable changes in fasting blood glucose based on available trial durations
• How long to take it: Short-term use (6–12 weeks) under medical supervision is the pattern established in clinical research. Long-term safety has not been established; extended use without monitoring is not recommended. Cycling with breaks is advisable given accumulation potential.